JP2022520572A5 - - Google Patents
Info
- Publication number
- JP2022520572A5 JP2022520572A5 JP2021547075A JP2021547075A JP2022520572A5 JP 2022520572 A5 JP2022520572 A5 JP 2022520572A5 JP 2021547075 A JP2021547075 A JP 2021547075A JP 2021547075 A JP2021547075 A JP 2021547075A JP 2022520572 A5 JP2022520572 A5 JP 2022520572A5
- Authority
- JP
- Japan
- Prior art keywords
- antibody
- light chain
- seq
- amino acid
- variable region
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2024197437A JP2025015588A (ja) | 2019-02-12 | 2024-11-12 | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962804721P | 2019-02-12 | 2019-02-12 | |
| US62/804,721 | 2019-02-12 | ||
| PCT/US2019/066648 WO2020167376A1 (en) | 2019-02-12 | 2019-12-16 | Treatment of al amyloidosis with the combination of monoclonal antibodies against immunoglobulin light chains and the cd38 cell membrane molecule on antibody-producing and other immune cells |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024197437A Division JP2025015588A (ja) | 2019-02-12 | 2024-11-12 | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520572A JP2022520572A (ja) | 2022-03-31 |
| JP2022520572A5 true JP2022520572A5 (https=) | 2022-12-22 |
Family
ID=69182616
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547075A Withdrawn JP2022520572A (ja) | 2019-02-12 | 2019-12-16 | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
| JP2024197437A Pending JP2025015588A (ja) | 2019-02-12 | 2024-11-12 | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024197437A Pending JP2025015588A (ja) | 2019-02-12 | 2024-11-12 | 免疫グロブリン軽鎖に対するモノクローナル抗体と、抗体産生細胞および他の免疫細胞上のｃｄ３８細胞膜分子に対するモノクローナル抗体の組み合わせによるａｌアミロイドーシスの処置 |
Country Status (17)
| Country | Link |
|---|---|
| US (2) | US20220213223A1 (https=) |
| EP (1) | EP3923954A1 (https=) |
| JP (2) | JP2022520572A (https=) |
| KR (1) | KR20210143752A (https=) |
| CN (2) | CN113924099A (https=) |
| AU (2) | AU2019429147B2 (https=) |
| BR (1) | BR112021015870A2 (https=) |
| CA (1) | CA3129890A1 (https=) |
| CL (1) | CL2021002140A1 (https=) |
| EA (1) | EA202192235A1 (https=) |
| IL (1) | IL285480A (https=) |
| JO (1) | JOP20210220A1 (https=) |
| MA (1) | MA54923A (https=) |
| MX (1) | MX2021009687A (https=) |
| PH (1) | PH12021551960A1 (https=) |
| SG (1) | SG11202108767PA (https=) |
| WO (1) | WO2020167376A1 (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4582446A3 (en) | 2019-03-05 | 2025-08-13 | Prothena Biosciences Limited | Methods of treating al amyloidosis |
| KR20230039734A (ko) | 2020-07-23 | 2023-03-21 | 오타이르 프로테나 리미티드 | 항-Aβ 항체 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20030147882A1 (en) | 1998-05-21 | 2003-08-07 | Alan Solomon | Methods for amyloid removal using anti-amyloid antibodies |
| AU2005235811B2 (en) | 2004-02-06 | 2011-11-03 | Morphosys Ag | Anti-CD38 human antibodies and uses therefor |
| JP5225069B2 (ja) | 2005-03-23 | 2013-07-03 | ゲンマブ エー／エス | 多発性骨髄腫の治療のためのｃｄ３８に対する抗体 |
| DK2237803T3 (en) | 2007-12-28 | 2015-10-05 | Prothena Biosciences Ltd | Treatment and prophylaxis of amyloidosis |
| SMT202000031T1 (it) | 2010-06-09 | 2020-03-13 | Genmab As | Anticorpi contro cd38 umano |
| CN107233569B (zh) | 2011-10-25 | 2021-08-31 | 普罗西纳生物科学有限公司 | 抗体制剂和方法 |
| CN108771655A (zh) | 2011-10-28 | 2018-11-09 | 诚信生物公司 | 含有氨基酸的蛋白质制剂 |
| EA201792546A1 (ru) | 2015-05-20 | 2018-04-30 | Янссен Байотек, Инк. | Антитела к cd38 для лечения амилоидоза легких цепей и прочих cd38-положительных гематологических злокачественных опухолей |
| CA3004152C (en) | 2015-11-03 | 2024-04-16 | Janssen Biotech, Inc. | Subcutaneous formulations of anti-cd38 antibodies and their uses |
| ES2914781T3 (es) * | 2016-06-30 | 2022-06-16 | Prothena Biosciences Ltd | Composiciones para el tratamiento de la amiloidosis |
-
2019
- 2019-12-16 JP JP2021547075A patent/JP2022520572A/ja not_active Withdrawn
- 2019-12-16 CA CA3129890A patent/CA3129890A1/en active Pending
- 2019-12-16 BR BR112021015870A patent/BR112021015870A2/pt unknown
- 2019-12-16 AU AU2019429147A patent/AU2019429147B2/en active Active
- 2019-12-16 US US17/429,876 patent/US20220213223A1/en not_active Abandoned
- 2019-12-16 EP EP19839484.3A patent/EP3923954A1/en active Pending
- 2019-12-16 KR KR1020217029118A patent/KR20210143752A/ko not_active Ceased
- 2019-12-16 SG SG11202108767PA patent/SG11202108767PA/en unknown
- 2019-12-16 EA EA202192235A patent/EA202192235A1/ru unknown
- 2019-12-16 MA MA054923A patent/MA54923A/fr unknown
- 2019-12-16 CN CN201980094744.5A patent/CN113924099A/zh active Pending
- 2019-12-16 WO PCT/US2019/066648 patent/WO2020167376A1/en not_active Ceased
- 2019-12-16 MX MX2021009687A patent/MX2021009687A/es unknown
- 2019-12-16 CN CN202510068246.0A patent/CN119950702A/zh active Pending
- 2019-12-16 PH PH1/2021/551960A patent/PH12021551960A1/en unknown
-
2021
- 2021-08-09 IL IL285480A patent/IL285480A/en unknown
- 2021-08-11 JO JOP/2021/0220A patent/JOP20210220A1/ar unknown
- 2021-08-12 CL CL2021002140A patent/CL2021002140A1/es unknown
-
2024
- 2024-10-18 US US18/920,634 patent/US20250075007A1/en active Pending
- 2024-11-12 JP JP2024197437A patent/JP2025015588A/ja active Pending
-
2025
- 2025-02-13 AU AU2025200997A patent/AU2025200997A1/en not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023544407A5 (https=) | ||
| JP2021526534A5 (https=) | ||
| JP2024534602A5 (https=) | ||
| JP2022522889A5 (https=) | ||
| US20250075007A1 (en) | Treatment of Al Amyloidosis with the Combination of Monoclonal Antibodies Agains Immunoglobulin Light Chains and the CD38 Cell Membrane Molecule on Antibody-Producing And Other Immune Cells | |
| JP2023520771A5 (https=) | ||
| JP2018533569A5 (https=) | ||
| JP2019519584A5 (https=) | ||
| JP2022520572A5 (https=) | ||
| JP2025502061A5 (https=) | ||
| JP2025509567A5 (https=) | ||
| JP2024525870A (ja) | 抗ｐｌａ２ｒ自己抗体媒介膜性腎症の治療 | |
| JP2023546504A5 (https=) | ||
| JP2023506779A5 (https=) | ||
| JP2022521773A5 (https=) | ||
| JP2024505923A5 (https=) | ||
| JP2020520905A5 (https=) | ||
| JP2022553378A5 (https=) | ||
| US20230338496A1 (en) | Vaccination against diabetes, obesity and complications thereof | |
| US11623003B2 (en) | Vaccination against diabetes, obesity and complications thereof | |
| EP3389704B1 (en) | Vaccination against diabetes, obesity and complications thereof | |
| EA047876B1 (ru) | Лечение al-амилоидоза комбинацией моноклональных антител против легких цепей иммуноглобулина и молекул клеточной мембраны cd38 в продуцирующих антитела и других иммунных клетках | |
| JP2021518393A5 (https=) | ||
| US20210017278A1 (en) | Treatment and Prophylaxis of Amyloidosis | |
| CN121889423A (zh) | 使用抗gfral抗体治疗恶心和呕吐病症的方法 |